Zequn, Z., Yujia, W., Dingding, Q., & Jiangfang, L. (2021). Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel. Eur J Pharmacol.
Citação norma ChicagoZequn, Zheng, Wu Yujia, Qian Dingding, and Lian Jiangfang. "Off-label Use of Chloroquine, Hydroxychloroquine, Azithromycin and Lopinavir/ritonavir in COVID-19 Risks Prolonging the QT Interval By Targeting the HERG Channel." Eur J Pharmacol 2021.
Citação norma MLAZequn, Zheng, Wu Yujia, Qian Dingding, and Lian Jiangfang. "Off-label Use of Chloroquine, Hydroxychloroquine, Azithromycin and Lopinavir/ritonavir in COVID-19 Risks Prolonging the QT Interval By Targeting the HERG Channel." Eur J Pharmacol 2021.